课题基金 / 基金详情

Therapy development for X-linked myotubular myopathy

Therapy development for X-linked myotubular myopathy
X连锁肌管肌病的治疗开发
批准号:
478411
负责人:
Dowling James
金额:
$69.66万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
未结题
起止时间:
2023-03-01 至 2028-03-01

项目摘要

项目成果

Dowling James的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
X-linked myotubular myopathy (XLMTM) is a severe childhood muscle disease associated with wheelchair and ventilator dependence and early death, with few affected children living to adulthood. The disease is caused by mutations in a gene named myotubularin
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of SPEG (Striated muscle preferentially expressed protein kinase) in skeletal muscle development and human muscle disease
  • 批准号:
    462458
  • 项目类别:
    Operating Grants
  • 资助金额:
    $66.88万
  • 财政年份:
    2022
  • 负责人:
    Dowling James
  • 依托单位:
Therapy development for X-linked myotubular myopathy
  • 批准号:
    477257
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2022
  • 负责人:
    Dowling James
  • 依托单位:
Novel therapies for neuromuscular diseases with altered phosphoinositide metabolism
  • 批准号:
    367426
  • 项目类别:
    Operating Grants
  • 资助金额:
    $10.93万
  • 财政年份:
    2017
  • 负责人:
    Dowling James
  • 依托单位:
Unraveling the genetics of malignant hyperthermia
  • 批准号:
    343736
  • 项目类别:
    Operating Grants
  • 资助金额:
    $69.62万
  • 财政年份:
    2016
  • 负责人:
    Dowling James
  • 依托单位:
海外基金